Sophie Lotersztajn
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy.
Journal: Annual review of pharmacology and toxicology
Published: September 11, 2024
Decompensated MASH-Cirrhosis Model by Acute and Toxic Effects of Phenobarbital.
Journal: Cells
Published: July 23, 2024
Defective autophagy in CD4 T cells drives liver fibrosis via type 3 inflammation.
Journal: Nature communications
Published: June 20, 2024
MAIT lymphocytes: A new therapeutic target in liver fibrosis
Journal: Medecine sciences : M/S
Published: September 11, 2023
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: January 10, 2023
Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration.
Journal: JHEP reports : innovation in hepatology
Published: October 20, 2022
Inflammation in alcohol-associated liver disease progression.
Journal: Zeitschrift fur Gastroenterologie
Published: January 18, 2022
Does CB-1 in hepatic stellate cells contribute to liver fibrosis?
Journal: The Journal of clinical investigation
Published: January 04, 2022
MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming.
Journal: Nature communications
Published: November 30, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Celebrating the third year of JHEP Reports in the COVID-19 era.
Journal: JHEP reports : innovation in hepatology
Published: January 08, 2021
Last Updated: 09/26/2026